Cargando…

N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis

Biomarker-guided treatments are needed in psychiatry, and previous data suggest oxidative stress may be a target in schizophrenia. A previous add-on trial with the antioxidant N-acetylcysteine (NAC) led to negative symptom reductions in chronic patients. We aim to study NAC’s impact on symptoms and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Conus, Philippe, Seidman, Larry J, Fournier, Margot, Xin, Lijing, Cleusix, Martine, Baumann, Philipp S, Ferrari, Carina, Cousins, Ann, Alameda, Luis, Gholam-Rezaee, Mehdi, Golay, Philippe, Jenni, Raoul, Woo, T -U Wilson, Keshavan, Matcheri S, Eap, Chin B, Wojcik, Joanne, Cuenod, Michel, Buclin, Thierry, Gruetter, Rolf, Do, Kim Q
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Regular Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815074/ https://www.ncbi.nlm.nih.gov/pubmed/29462456 http://dx.doi.org/10.1093/schbul/sbx093

Ejemplares similares

F44. AN ADD-ON TRIAL WITH N-ACETYL-CYSTEINE (NAC) IN EARLY PSYCHOSIS PATIENTS: TOWARDS BIOMARKER GUIDED TREATMENT
por: Conus, Philippe, et al.
Publicado: (2018)

N-acetylcysteine add-on treatment leads to an improvement of fornix white matter integrity in early psychosis: a double-blind randomized placebo-controlled trial
por: Klauser, Paul, et al.
Publicado: (2018)

Topology predicts long-term functional outcome in early psychosis
por: Fournier, Margot, et al.
Publicado: (2020)

T52. N-ACETYL-CYSTEINE ADD-ON TREATMENT LEADS TO AN IMPROVEMENT OF FORNIX WHITE MATTER INTEGRITY IN EARLY PSYCHOSIS
por: Klauser, Paul, et al.
Publicado: (2018)

16.2 CHILDHOOD TRAUMA ENGAGES OXIDATIVE STRESS, HIPPOCAMPUS ALTERATIONS, AND POORER CLINICAL OUTCOME IN EARLY PSYCHOSIS PATIENTS
por: Alameda, Luis, et al.
Publicado: (2018)

M16. PROFILING GLUTAMATE AND D-SERINE PATHWAYS IN TREATMENT RESISTANT EARLY PSYCHOSIS PATIENTS
por: Camporesi, Sara, et al.
Publicado: (2020)

Redox dysregulation as a link between childhood trauma and psychopathological and neurocognitive profile in patients with early psychosis
por: Alameda, Luis, et al.
Publicado: (2018)

10.2 REDOX DYSREGULATION, OLIGODENDROCYTES AND WHITE MATTER ALTERATIONS IN SCHIZOPHRENIA
por: Klauser, Paul, et al.
Publicado: (2018)

Characterization of early psychosis patients carrying a genetic vulnerability to redox dysregulation: a computational analysis of mechanism-based gene expression profile in fibroblasts
por: Giangreco, Basilio, et al.
Publicado: (2023)

F227. PSYCHOLOGICAL TRAUMA OCCURRING DURING ADOLESCENCE IS ASSOCIATED WITH AN INCREASED RISK OF GREATER WAIST CIRCUMFERENCE IN EARLY PSYCHOSIS PATIENTS INDEPENDENTLY OF MEDICATION
por: Alameda, Luis, et al.
Publicado: (2018)

N-Acetyl-Cysteine Supplementation Improves Functional Connectivity Within the Cingulate Cortex in Early Psychosis: A Pilot Study
por: Mullier, Emeline, et al.
Publicado: (2019)

Early onset of cannabis use and violent behavior in psychosis
por: Moulin, Valerie, et al.
Publicado: (2020)

Psychological trauma occurring during adolescence is associated with an increased risk of greater waist circumference in Early Psychosis patients treated with psychotropic medication
por: Alameda, Luis, et al.
Publicado: (2020)

Timely N-Acetyl-Cysteine and Environmental Enrichment Rescue Oxidative Stress-Induced Parvalbumin Interneuron Impairments via MMP9/RAGE Pathway: A Translational Approach for Early Intervention in Psychosis
por: Dwir, Daniella, et al.
Publicado: (2021)

Impaired fornix–hippocampus integrity is linked to peripheral glutathione peroxidase in early psychosis
por: Baumann, P S, et al.
Publicado: (2016)

Bridging structural MRI with cognitive function for individual level classification of early psychosis via deep learning
por: Wen, Yang, et al.
Publicado: (2023)

Evolution of impulsivity levels in relation to early cannabis use in violent patients in the early phase of psychosis
por: Dan-Glauser, Elise, et al.
Publicado: (2023)

Time of exposure to social defeat stress during childhood and adolescence and redox dysregulation on long-lasting behavioral changes, a translational study
por: Schnider, Mirko, et al.
Publicado: (2022)

S180. MICROSTRUCTURE COMPLEXITY OF THE THALAMUS IN SCHIZOPHRENIA: A NODDI STUDY
por: Alemán-Gómez, Yasser, et al.
Publicado: (2018)

MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patients
por: Dwir, Daniella, et al.
Publicado: (2019)

Brain connectivity alterations in early psychosis: from clinical to neuroimaging staging
por: Griffa, Alessandra, et al.
Publicado: (2019)

Mitochondrial, exosomal miR137-COX6A2 and gamma synchrony as biomarkers of parvalbumin interneurons, psychopathology, and neurocognition in schizophrenia
por: Khadimallah, Ines, et al.
Publicado: (2021)

Gene set enrichment analysis of pathophysiological pathways highlights oxidative stress in psychosis
por: Pistis, Giorgio, et al.
Publicado: (2022)

City Avoidance in the Early Phase of Psychosis: A Neglected Domain of Assessment and a Potential Target for Recovery Strategies
por: Conus, Philippe, et al.
Publicado: (2019)

Dynamics between insight and medication adherence in first-episode psychosis: Study of 3-year trajectories
por: Elowe, Julien, et al.
Publicado: (2022)

Cannabis, a Significant Risk Factor for Violent Behavior in the Early Phase Psychosis. Two Patterns of Interaction of Factors Increase the Risk of Violent Behavior: Cannabis Use Disorder and Impulsivity; Cannabis Use Disorder, Lack of Insight and Treatment Adherence
por: Moulin, Valerie, et al.
Publicado: (2018)

Psychotropic drug-induced genetic-epigenetic modulation of CRTC1 gene is associated with early weight gain in a prospective study of psychiatric patients
por: Delacrétaz, Aurélie, et al.
Publicado: (2019)

Prevalence of ECG abnormalities and risk factors for QTc interval prolongation in hospitalized psychiatric patients
por: Ansermot, Nicolas, et al.
Publicado: (2019)

Insight as a social identity process in the evolution of psychosocial functioning in the early phase of psychosis
por: Klaas, H. S., et al.
Publicado: (2017)

Internal and Predictive Validity of the French Health of the Nation Outcome Scales: Need for Future Directions
por: Golay, Philippe, et al.
Publicado: (2016)

Association Between Plasma Caffeine and Other Methylxanthines and Metabolic Parameters in a Psychiatric Population Treated With Psychotropic Drugs Inducing Metabolic Disturbances
por: Delacrétaz, Aurélie, et al.
Publicado: (2018)

S164. “AT-RISK MENTAL STATES” PROGRAM IN LAUSANNE: INFLUENCE OF RECRUITMENT STRATEGIES ON THE RATE OF FALSE POSITIVES
por: Solida, Alessandra, et al.
Publicado: (2018)

Stable biomarker identification for predicting schizophrenia in the human connectome
por: Gutiérrez-Gómez, Leonardo, et al.
Publicado: (2020)

Pandemics and psychiatry: Repositioning research in context of COVID-19
por: Keshavan, Matcheri S.
Publicado: (2020)

Building resilience in the COVID-19 era: Three paths in the Bhagavad Gita
por: Keshavan, Matcheri S.
Publicado: (2020)

Metabolomic alteration induced by psychotropic drugs: Short‐term metabolite profile as a predictor of weight gain evolution
por: Lenski, Marie, et al.
Publicado: (2021)

Correction: Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort
por: Dubath, Céline, et al.
Publicado: (2021)

Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort
por: Dubath, Céline, et al.
Publicado: (2021)

S69. CLINICAL HIGH RISK STATE: STRATIFICATION BASED ON CLINICAL PROFILE AND REDOX STATUS
por: Cleusix, Martine, et al.
Publicado: (2020)

Influence of MCHR2 and MCHR2-AS1 Genetic Polymorphisms on Body Mass Index in Psychiatric Patients and In Population-Based Subjects with Present or Past Atypical Depression
por: Delacrétaz, Aurélie, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ijnmp0nrm04ud6olmqv5mioi7b